CIRCADIAN NEUROENDOCRINE RESETTING THERAPY Trademark

Trademark Overview

On Thursday, May 13, 2010, a trademark application was filed for CIRCADIAN NEUROENDOCRINE RESETTING THERAPY with the United States Patent and Trademark Office. The USPTO has given the CIRCADIAN NEUROENDOCRINE RESETTING THERAPY trademark a serial number of 85037493. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, August 31, 2021. This trademark is owned by VeroScience LLC. The CIRCADIAN NEUROENDOCRINE RESETTING THERAPY trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Treatment of obesity, lipid disorders, metabolic disorders, cardiovascular diseases, diseases of the immune system, age-related diseases, cancer, and diseases caused by diabetes such as diabetic neuropathy, obesity, dyslipidemia, hypercholestermia, and hypertension through the therapy of changing the aberrant phase relationships of specific pacemaker biological clock circadian peak neuronal outputs, e.g., messaging or transmission, within the central nervous system
circadian neuroendocrine resetting therapy

General Information

Serial Number85037493
Word MarkCIRCADIAN NEUROENDOCRINE RESETTING THERAPY
Filing DateThursday, May 13, 2010
Status800 - REGISTERED AND RENEWED
Status DateTuesday, August 31, 2021
Registration Number3952824
Registration DateTuesday, April 26, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"THERAPY"
Goods and ServicesTreatment of obesity, lipid disorders, metabolic disorders, cardiovascular diseases, diseases of the immune system, age-related diseases, cancer, and diseases caused by diabetes such as diabetic neuropathy, obesity, dyslipidemia, hypercholestermia, and hypertension through the therapy of changing the aberrant phase relationships of specific pacemaker biological clock circadian peak neuronal outputs, e.g., messaging or transmission, within the central nervous system
Pseudo MarkCIRCADIAN NEURO ENDOCRINE RESETTING THERAPY

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2010
Primary Code044
First Use Anywhere DateSunday, January 16, 2011
First Use In Commerce DateSunday, January 16, 2011

Trademark Owner History

Party NameVeroScience LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressTiverton, RI 02878
Party NameVeroScience LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTiverton, RI 02878

Trademark Events

Event DateEvent Description
Tuesday, August 31, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, August 31, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, August 31, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 30, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, August 24, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, August 11, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 23, 2021TEAS SECTION 8 & 9 RECEIVED
Sunday, April 26, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, May 17, 2016NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, May 17, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, May 17, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 26, 2016TEAS SECTION 8 RECEIVED
Tuesday, April 26, 2011REGISTERED-SUPPLEMENTAL REGISTER
Monday, March 21, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 18, 2011ASSIGNED TO LIE
Wednesday, March 2, 2011NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, March 1, 2011APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, March 1, 2011USE AMENDMENT ACCEPTED
Tuesday, March 1, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 28, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 28, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 23, 2011AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, February 23, 2011USE AMENDMENT FILED
Tuesday, February 22, 2011TEAS AMENDMENT OF USE RECEIVED
Tuesday, August 31, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 31, 2010NON-FINAL ACTION E-MAILED
Tuesday, August 31, 2010NON-FINAL ACTION WRITTEN
Thursday, August 26, 2010ASSIGNED TO EXAMINER
Thursday, May 20, 2010NOTICE OF PSEUDO MARK MAILED
Wednesday, May 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 17, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapy resetting neuroendocrine circadian diseases system disorders obesity pacemaker biological clock relationships aberrant phase